The fact
The $1.3 billion deal strengthens Ipsen's position in hematology.
This acquisition is part of an accelerated external growth strategy.
Click the link to read an article on the topic:
The $1.3 billion deal strengthens Ipsen's position in hematology.
This acquisition is part of an accelerated external growth strategy.